Literature DB >> 19148341

Peripheral arterial disease: lack of awareness in Canada.

Marge Lovell1, Kenneth Harris, Thomas Forbes, Gwen Twillman, Beth Abramson, Michael H Criqui, Paul Schroeder, Emile R Mohler, Alan T Hirsch.   

Abstract

BACKGROUND: Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis and is associated with a high risk of stroke, myocardial infarction and cardiovascular death. PAD also fosters major morbidity by causing claudication, functional impairment, disability and amputation. PAD is largely unrecognized and under-treated compared with other cardiovascular diseases. The public health impact of PAD, as a contributor to Canadian national rates of heart attack, stroke, amputation, death and disability, will be challenging to address if the public is unaware of this common cardiovascular disease.
OBJECTIVE: To assess public knowledge of PAD in Canada.
METHODS: A cross-sectional, population-based telephone survey of 501 adults 50 years of age and older (mean age 64.4 years) was conducted using random digit dialing. The survey assessed demographics and risk factors of the study population and knowledge of PAD causes and consequences.
RESULTS: Survey respondents reported a high prevalence of atherosclerotic risk factors including high blood pressure (43%), high blood cholesterol (37%), diabetes (12%) and smoking history (18% current and 49% former smokers). Only 36% of respondents reported familiarity with PAD, which was significantly lower than other cardiovascular diseases or risk factors. Knowledge of perceived consequences of PAD was low and knowledge gaps were more pronounced in older, less educated and lower income respondents.
CONCLUSIONS: The Canadian public is largely unaware of PAD as a prevalent systemic manifestation of atherosclerosis and its associated morbidity and mortality. National PAD awareness programs should be instituted to increase PAD knowledge to levels comparable with other cardiovascular diseases and risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19148341      PMCID: PMC2691879          DOI: 10.1016/s0828-282x(09)70021-2

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  35 in total

Review 1.  Critical issues in peripheral arterial disease detection and management: a call to action.

Authors:  Jill J F Belch; Eric J Topol; Giancarlo Agnelli; Michel Bertrand; Robert M Califf; Denis L Clement; Mark A Creager; J Donald Easton; James R Gavin; Philip Greenland; Graeme Hankey; Peter Hanrath; Alan T Hirsch; Jürgen Meyer; Sidney C Smith; Frank Sullivan; Michael A Weber
Journal:  Arch Intern Med       Date:  2003-04-28

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Peripheral arterial disease--epidemiological aspects.

Authors:  M H Criqui
Journal:  Vasc Med       Date:  2001       Impact factor: 3.239

4.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

5.  Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status.

Authors:  L Potvin; L Richard; A C Edwards
Journal:  CMAJ       Date:  2000       Impact factor: 8.262

Review 6.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

Authors:  Joshua A Beckman; Mark A Creager; Peter Libby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

7.  Tracking women's awareness of heart disease: an American Heart Association national study.

Authors:  Lori Mosca; Anjanette Ferris; Rosalind Fabunmi; Rose Marie Robertson
Journal:  Circulation       Date:  2004-02-04       Impact factor: 29.690

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

Authors:  Curt Diehm; Alexander Schuster; Jens R Allenberg; Harald Darius; Roman Haberl; Stefan Lange; David Pittrow; Berndt von Stritzky; Gerhart Tepohl; Hans-Joachim Trampisch
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

Review 10.  Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health.

Authors:  Alan T Hirsch; Peter Gloviczki; Alain Drooz; Marge Lovell; Mark A Creager
Journal:  J Vasc Surg       Date:  2004-02       Impact factor: 4.268

View more
  21 in total

1.  One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  Kim G Smolderen; Alan Bell; Yang Lei; Eric A Cohen; P Gabriel Steg; Deepak L Bhatt; Elizabeth M Mahoney
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

2.  The level of knowledge of risk factors for peripheral arterial disease also depends on subjects' individual clinical situations.

Authors:  Victor Aboyans; Philippe Lacroix; Marc Laskar
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

3.  Socioeconomic inequality and peripheral artery disease prevalence in US adults.

Authors:  Reena L Pande; Mark A Creager
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07

4.  Population-based risk factors for community-onset bloodstream infections.

Authors:  Kevin B Laupland; Kelsey Pasquill; Gabrielle Dagasso; Elizabeth C Parfitt; Lisa Steele; Henrik C Schonheyder
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-19       Impact factor: 3.267

Review 5.  Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2015-11-01

6.  Treatment of Superficial Femoral Artery Restenosis.

Authors:  Andrew J Miller; Edwin A Takahashi; William S Harmsen; Kristin C Mara; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2017-09-19       Impact factor: 3.464

7.  Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-09-01

Review 8.  Building a Critical Limb Ischemia Program.

Authors:  Andrew M Galmer; Samy M Selim; Jay Giri; Joe F Lau; Mitchell D Weinberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

9.  Sex differences in the outcomes of peripheral arterial disease: a population-based cohort study.

Authors:  Mohamad A Hussain; Thomas F Lindsay; Muhammad Mamdani; Xuesong Wang; Subodh Verma; Mohammed Al-Omran
Journal:  CMAJ Open       Date:  2016-03-30

Review 10.  Peripheral artery disease among Indigenous Canadians: What do we know?

Authors:  Christopher Bonneau; Nadine R. Caron; Mohamad A. Hussain; Ahmed Kayssi; Subodh Verma; Mohammed Al-Omran
Journal:  Can J Surg       Date:  2018-10-01       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.